4.8 Article

Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Building ubiquitination machineries: E3 ligase multi-subunit assembly and substrate targeting by PROTACs and molecular glues

Sarath Ramachandran et al.

Summary: E3 ubiquitin ligase machineries are attractive therapeutic targets for targeted protein degradation due to their specificity to substrate ubiquitination. Recent advances have focused on elucidating the modular assembly of E3 ligase complexes and studying their structures bound to neo-substrates and degrader molecules. Understanding these ternary complexes is crucial for structure-based degrader design.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)

Article Chemistry, Medicinal

Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity

Xuan Zhang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics

Sajid Khan et al.

ONCOGENE (2020)

Article Chemistry, Medicinal

PRosettaC: Rosetta Based Modeling of PROTAC Mediated Ternary Complexes

Daniel Zaidman et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Article Biochemistry & Molecular Biology

Exploring Targeted Degradation Strategy for Oncogenic KRASG12C

Mei Zeng et al.

CELL CHEMICAL BIOLOGY (2020)

Article Chemistry, Medicinal

Selective degradation of CDK6 by a palbociclib based PROTAC

Sandeep Rana et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Review Biochemistry & Molecular Biology

The Structural Biology of Bcl-xL

Erinna F. Lee et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemistry & Molecular Biology

A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity

Sajid Khan et al.

NATURE MEDICINE (2019)

Article Multidisciplinary Sciences

Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase

Blake E. Smith et al.

NATURE COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate

Michael J. Roy et al.

ACS CHEMICAL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

PROTACs: great opportunities for academia and industry

Xiuyun Sun et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)

Article Chemistry, Medicinal

A Click Chemistry Platform for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation

Ryan P. Wurz et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Cell Biology

Oxidation resistance 1 is a novel senolytic target

Xin Zhang et al.

AGING CELL (2018)

Article Biochemistry & Molecular Biology

Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead

Daniel P. Bondeson et al.

CELL CHEMICAL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Structural basis of PROTAC cooperative recognition for selective protein degradation

Morgan S. Gadd et al.

NATURE CHEMICAL BIOLOGY (2017)

Review Biotechnology & Applied Microbiology

From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors

Avi Ashkenazi et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Biochemistry & Molecular Biology

DynOmics: dynamics of structural proteome and beyond

Hongchun Li et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Biochemistry & Molecular Biology

Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase Complex

Teresa A. F. Cardote et al.

STRUCTURE (2017)

Review Biochemistry & Molecular Biology

Progress in targeting the BCL-2 family of proteins

Thomas P. Garner et al.

CURRENT OPINION IN CHEMICAL BIOLOGY (2017)

Article Chemistry, Multidisciplinary

Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)

Caroline M. Robb et al.

CHEMICAL COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Cullin neddylation may allosterically tune polyubiquitin chain length and topology

Melis Onel et al.

BIOCHEMICAL JOURNAL (2017)

Article Chemistry, Multidisciplinary

Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL

Ashton C. Lai et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Review Biochemistry & Molecular Biology

Attacking cancer's Achilles heel: antagonism of antiapoptotic BCL-2 family members

Joseph T. Opferman

FEBS JOURNAL (2016)

Article Multidisciplinary Sciences

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

Andras Kotschy et al.

NATURE (2016)

Review Biochemistry & Molecular Biology

Lysine-targeting specificity in ubiquitin and ubiquitin-like modification pathways

Francesca Mattiroli et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)

Review Pharmacology & Pharmacy

Targeting the Bcl-2 family for cancer therapy

Shibu Thomas et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2013)

Article Biochemistry & Molecular Biology

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Andrew J. Souers et al.

NATURE MEDICINE (2013)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Biochemistry & Molecular Biology

Flexible Cullins in Cullin-RING E3 Ligases Allosterically Regulate Ubiquitination

Jin Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Review Biochemistry & Molecular Biology

The Bcl-2 apoptotic switch in cancer development and therapy

J. M. Adams et al.

ONCOGENE (2007)

Review Biochemistry & Molecular Biology

Structural biology of the Bcl-2 family of proteins

AM Petros et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)

Article Biochemistry & Molecular Biology

Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations

JJ Gray et al.

JOURNAL OF MOLECULAR BIOLOGY (2003)